OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 127 filers reported holding OCULAR THERAPEUTIX INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $263 | +198.9% | 28,946 | +47.3% | 0.00% | 0.0% |
Q4 2023 | $88 | +131.6% | 19,646 | +60.5% | 0.00% | – |
Q3 2023 | $38 | -78.7% | 12,242 | -63.8% | 0.00% | -100.0% |
Q1 2023 | $178 | -99.7% | 33,849 | +121.5% | 0.00% | +100.0% |
Q3 2022 | $63,000 | +53.7% | 15,285 | +51.4% | 0.00% | – |
Q2 2022 | $41,000 | -68.0% | 10,094 | -45.2% | 0.00% | -100.0% |
Q4 2021 | $128,000 | -67.3% | 18,415 | -52.9% | 0.00% | -50.0% |
Q3 2021 | $391,000 | +58.3% | 39,101 | +159.4% | 0.00% | +100.0% |
Q1 2021 | $247,000 | +10.8% | 15,072 | +39.8% | 0.00% | 0.0% |
Q4 2020 | $223,000 | -5.5% | 10,778 | -62.0% | 0.00% | -50.0% |
Q2 2020 | $236,000 | +206.5% | 28,347 | +82.1% | 0.00% | +100.0% |
Q1 2020 | $77,000 | +140.6% | 15,568 | +47.5% | 0.00% | – |
Q3 2019 | $32,000 | -93.0% | 10,553 | -78.5% | 0.00% | -100.0% |
Q1 2017 | $455,000 | +337.5% | 49,024 | +1884.0% | 0.00% | +300.0% |
Q1 2015 | $104,000 | – | 2,471 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 5,618,861 | $79,675,000 | 100.00% |
Opaleye Management Inc. | 6,480,000 | $91,886,000 | 15.26% |
DELTEC ASSET MANAGEMENT LLC | 2,167,313 | $30,732,000 | 4.23% |
Kamunting Street Capital Management, L.P. | 624,201 | $8,851,000 | 3.58% |
GREAT POINT PARTNERS LLC | 919,887 | $13,044,000 | 2.74% |
Endurant Capital Management LP | 570,970 | $8,096,000 | 2.22% |
Rubric Capital Management LP | 2,156,542 | $30,580,000 | 1.92% |
Affinity Asset Advisors, LLC | 250,000 | $3,545,000 | 1.27% |
Altium Capital Management LP | 256,152 | $3,632,000 | 0.84% |
Ikarian Capital, LLC | 700,000 | $9,928,000 | 0.80% |